30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

60 Degrees Pharmaceuticals Inc (SXTP)

Track

Over the last 90 days, insider trading activity at 60 Degrees Pharmaceuticals Inc. shows a net buy of $10,131.24, with one executive making a purchase. The company's stock has experienced a 29.7% decline over the past 90 days. The last reported earnings showed a significant miss.
Stock chart
Ticker: SXTP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
DOW GEOFFREY S
President and CEO
1 purchase — total 100,000 USD
Buy 12 Jun 2026
Value US$3,721,707.16 | Price 253.02 | Shares 30,722
Buy 15 Dec 2025
Value US$2,799,551.20 | Price 391.91 | Shares 75,707
Buy 11 Dec 2025
Value US$3,318.18 | Price 0.92 | Shares 3,613
Buy 10 Dec 2025
Value US$8,886.24 | Price 0.95 | Shares 9,350
Buy 3 Jun 2025
Value US$5,800.00 | Price 2.90 | Shares 2,000
Buy 3 Jun 2025
Value US$8,610.00 | Price 2.87 | Shares 3,000
Buy 16 Dec 2024
Value US$2,900.00 | Price 1.45 | Shares 2,000
Buy 13 Dec 2024
Value US$2,280.00 | Price 1.52 | Shares 1,500
Buy 13 Dec 2024
Value US$2,325.00 | Price 1.55 | Shares 1,500
Buy 13 Dec 2024
Value US$2,370.00 | Price 1.58 | Shares 1,500
Buy 13 Dec 2024
Value US$2,400.00 | Price 1.60 | Shares 1,500
Buy 12 Dec 2024
Value US$4,500.00 | Price 1.80 | Shares 2,500
Buy 12 Dec 2024
Value US$4,625.00 | Price 1.85 | Shares 2,500
Buy 9 Dec 2024
Value US$45,563.27 | Price 1.27 | Shares 35,823
Buy 6 Dec 2024
Value US$24,672.16 | Price 1.20 | Shares 20,579
Buy 5 Dec 2024
Value US$19,519.75 | Price 1.11 | Shares 17,549
Buy 21 Nov 2024
Value US$3,195.15 | Price 0.91 | Shares 3,500
Buy 20 Nov 2024
Value US$924.30 | Price 0.92 | Shares 1,000
Buy 19 Nov 2024
Value US$2,248.00 | Price 0.90 | Shares 2,500
Buy 27 Aug 2024
Value US$8,500.00 | Price 1.70 | Shares 5,000
Buy 31 Jan 2024
Value US$75,000.00 | Price 0.38 | Shares 200,000
Buy 31 Jan 2024
Value US$9,740.25 | Price 0.38 | Shares 25,974
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
30,722 -4.8%
253.02
US$3,721,707 		30,722 -4.8% 253.02 US$3,721,707
2025-12-16 2025-12-15 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
75,707 +24.7%
391.91
US$2,799,551 		75,707 +24.7% 391.91 US$2,799,551
2025-12-12 2025-12-11 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
67,813 +23.0%
209.71
US$2,676,703 		67,813 +23.0% 209.71 US$2,676,703
2025-12-12 2025-12-10 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
9,350 +25.3%
0.95
US$8,886 		9,350 +25.3% 0.95 US$8,886
2025-06-05 2025-06-03 B Purchase
1.4
XU CHERYL
Non-Executive Director
2,000 +14.5%
2.90
US$5,800 		2,000 +14.5% 2.90 US$5,800
2025-06-05 2025-06-03 B Purchase
1.4
XU CHERYL
Non-Executive Director
3,000 +27.7%
2.87
US$8,610 		3,000 +27.7% 2.87 US$8,610
2024-12-18 2024-12-16 B Purchase
1.4
XU CHERYL
Non-Executive Director
2,000 +3.8%
1.45
US$2,900 		2,000 +3.8% 1.45 US$2,900
2024-12-18 2024-12-13 B Purchase
1.4
XU CHERYL
Non-Executive Director
1,500 +3.0%
1.52
US$2,280 		1,500 +3.0% 1.52 US$2,280
2024-12-18 2024-12-13 B Purchase
1.4
XU CHERYL
Non-Executive Director
1,500 +3.1%
1.55
US$2,325 		1,500 +3.1% 1.55 US$2,325
2024-12-18 2024-12-13 B Purchase
1.4
XU CHERYL
Non-Executive Director
1,500 +3.2%
1.58
US$2,370 		1,500 +3.2% 1.58 US$2,370
2024-12-18 2024-12-13 B Purchase
1.4
XU CHERYL
Non-Executive Director
1,500 +3.3%
1.60
US$2,400 		1,500 +3.3% 1.60 US$2,400
2024-12-18 2024-12-12 B Purchase
1.4
XU CHERYL
Non-Executive Director
2,500 +5.7%
1.80
US$4,500 		2,500 +5.7% 1.80 US$4,500
2024-12-18 2024-12-12 B Purchase
1.4
XU CHERYL
Non-Executive Director
2,500 +6.1%
1.85
US$4,625 		2,500 +6.1% 1.85 US$4,625
2024-12-09 2024-12-09 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
35,823 +61.0%
1.27
US$45,563 		35,823 +61.0% 1.27 US$45,563
2024-12-09 2024-12-06 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
20,579 +53.9%
1.20
US$24,672 		20,579 +53.9% 1.20 US$24,672
2024-12-09 2024-12-05 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
17,549 +85.1%
1.11
US$19,520 		17,549 +85.1% 1.11 US$19,520
2024-11-21 2024-11-21 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
3,500 +20.4%
0.91
US$3,195 		3,500 +20.4% 0.91 US$3,195
2024-11-21 2024-11-20 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
1,000 +6.2%
0.92
US$924 		1,000 +6.2% 0.92 US$924
2024-11-21 2024-11-19 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
2,500 +18.3%
0.90
US$2,248 		2,500 +18.3% 0.90 US$2,248
2024-09-11 2024-08-27 B Purchase
1.4
XU CHERYL
Non-Executive Director
5,000 +13.9%
1.70
US$8,500 		5,000 +13.9% 1.70 US$8,500
2024-02-02 2024-01-31 B Purchase
1.4
XU CHERYL
Non-Executive Director
200,000 +88.9%
0.38
US$75,000 		200,000 +88.9% 0.38 US$75,000
2024-02-02 2024-01-31 B Purchase
1.4
DOW GEOFFREY S

President and CEO

Executive Director
25,974 +3.8%
0.38
US$9,740 		25,974 +3.8% 0.38 US$9,740
Explore more

More insider trading research around 60 Degrees Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America